Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...

Healthcare providers often recommend non-steroidal anti-inflammatory drugs (NSAIDs), such as Aleve (naproxen ... The most common cause of peripheral neuropathy is diabetes. Treatment for this ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

On Wednesday, Sonnet’s stock saw a dramatic rise, making it one of the most talked-about biotech stocks of the day. This uptick comes in the wake of a key announcement from the company: the issuance ...

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

The nationwide recall of more than 7000 bottles of duloxetine delayed-release capsules is due to unacceptable levels of a ...

Researchers found that neuromuscular training significantly reduces the incidence and severity of chemotherapy-induced peripheral neuropathy, improving patient quality of life and treatment outcomes.

manufacture and commercialise the drug candidate “SON-080” for the treatment of diabetic peripheral neuropathy in India. According to a press statement, “SON-080” is Sonnet’s proprietary ...